NRC Inspection Team to Present Findings of its Review of Possible Radiation Overexposures at Mallinckrodt Facility
U. S. NUCLEAR REGULATORY COMMISSION
801 Warrenville Road, Lisle IL 60532
|No. III-00-29||June 16, 2000|
|CONTACT:||Jan Strasma (630)829-9663/e-mail: email@example.com|
Pam Alloway-Mueller (630)829-9662/e-mail: firstname.lastname@example.org
NRC INSPECTION TEAM TO PRESENT FINDINGS OF ITS REVIEW OF POSSIBLE
RADIATION OVEREXPOSURES AT MALLINCKRODT FACILITY
A Nuclear Regulatory Commission special inspection team will meet Friday, June 23, with Mallinckrodt, Inc., officials in Maryland Heights, Missouri, to discuss the results of the team's review of possible radiation overexposures at the company's plant there. The meeting will be open to public observation.
The meeting will be at 9:30 a.m. in the Maryland Heights Community Center, Room 3, 2344 McKelvey Road.
Mallinckrodt produces radioactive drugs that are used in research and in routine medical diagnosis and therapy. The company's processing and distribution of radioactive materials is regulated by the NRC and, for certain materials produced in a particle accelerator, by the State of Missouri.
The review by the NRC Augmented Inspection Team began in early May after the company reported a possible radiation overexposure to a worker's hand on April 13 and subsequently identified other work areas at its plant where workers might have received radiation exposures to their hands above NRC limits.
The team included four NRC inspectors and a State of Missouri inspector.
The Augmented Inspection Team will issue a written report in several weeks. A future NRC inspection will review the team's findings to determine if any enforcement action is appropriate.